BCR | 22q11.23 | ALL, CML, PHL, BCR1, D22S11, D22S662 | Translocation
| -BCR-ABL Translocation in Acute Lymphoblastic Leukaemia -BCR and Acute Lymphocytic Leukaemia
| 1179 |
IGH | 14q32.33 | IGD1, IGH@, IGHJ, IGHV, IGHD@, IGHJ@, IGHV@, IGH.1@, IGHDY1 | | -IGH and Acute Lymphocytic Leukaemia
| 237 |
CD34 | 1q32.2 | | | -CD34 and Acute Lymphocytic Leukaemia
| 217 |
PBX1 | 1q23.3 | CAKUHED | | -PBX1 and Acute Lymphocytic Leukaemia
| 201 |
MLLT10 | 10p12.31 | AF10 | Translocation
| -t(10;11)(p13;q14) AF10-PICALM translocation in Acute Leukaemia -t(10;11)(p12;q23) AF10-MLL translocation in Acute Leukaemia
| 122 |
IKZF1 | 7p12.2 | IK1, LYF1, LyF-1, CVID13, IKAROS, PPP1R92, PRO0758, ZNFN1A1, Hs.54452 | | -IKZF1 and Acute Lymphocytic Leukaemia
| 165 |
MTHFR | 1p36.22 | | | -MTHFR and Acute Lymphocytic Leukaemia
| 155 |
KMT2A | 11q23.3 | HRX, MLL, MLL1, TRX1, ALL-1, CXXC7, HTRX1, MLL1A, WDSTS | Translocation
| -t(4;11)(q21;q23) MLL-AFF1 in adult acute lymphoblastic leukemia -t(10;11)(p12;q23) AF10-MLL translocation in Acute Leukaemia -t(10;11) MLL-TET1 rearrangement in acute leukemias -t(11;19)(q23;p13.1) MLL-ELL translocation in acute leukaemia
| 122 |
KITLG | 12q22 | SF, MGF, SCF, FPH2, FPHH, KL-1, Kitl, SHEP7 | | -KITLG and Acute Lymphocytic Leukaemia
| 139 |
RB1 | 13q14.2 | RB, pRb, OSRC, pp110, p105-Rb, PPP1R130 | | -RB1 and Acute Leukaemias
| 125 |
CD33 | 19q13.41 | p67, SIGLEC3, SIGLEC-3 | | -CD33 and Acute Lymphocytic Leukaemia
| 97 |
CD9 | 12p13.31 | MIC3, MRP-1, BTCC-1, DRAP-27, TSPAN29, TSPAN-29 | | -CD9 and Acute Lymphocytic Leukaemia
| 90 |
PICALM | 11q14.2 | LAP, CALM, CLTH | Translocation
| -t(10;11)(p13;q14) AF10-PICALM translocation in Acute Leukaemia
| 76 |
PDGFRA | 4q12 | CD140A, PDGFR2, PDGFR-2 | Deletion / Translocation
| -FIP1L1-PDGFRA fusion in Leukemia
| 72 |
FIP1L1 | 4q12 | Rhe, FIP1, hFip1 | Deletion / Translocation
| -FIP1L1-PDGFRA fusion in Leukemia
| 72 |
CDKN2B | 9p21.3 | P15, MTS2, TP15, CDK4I, INK4B, p15INK4b | | -CDKN2B and Acute Lymphocytic Leukaemia
| 70 |
HLF | 17q22 | | Translocation
| -t(17;19)(q22;p13) TCF3-HLF fusion in Acute Lymphoblastic Leukemia -HLF and Acute Lymphocytic Leukaemia
| 35 |
LMO2 | 11p13 | TTG2, RBTN2, RHOM2, RBTNL1 | | -LMO2 and T-Cell Acute Lymphocytic Leukaemia
| 63 |
ETV6 | 12p13.2 | TEL, THC5, TEL/ABL | Translocation
| -t(1;12)(q25;p13) in Leukaemia (AML & ALL) -t(12;21) in Adult Lyphocytic Leukaemia
| 38 |
CRLF2 | Xp22.3; Yp11.3 | CRL2, TSLPR, CRLF2Y | | -CRLF2 and Acute Lymphocytic Leukaemia
| 60 |
NOTCH1 | 9q34.3 | hN1, AOS5, TAN1, AOVD1 | Translocation
| -t(7;9)(q34;q34) in T-Cell Acute Lymphoblastic Leukaemia -NOTCH1 mutations in T cell acute lymphoblastic leukemia (T-ALL)
| 48 |
JAK1 | 1p31.3 | JTK3, JAK1A, JAK1B | | -JAK1 and Acute Lymphocytic Leukaemia
| 48 |
FBXW7 | 4q31.3 | AGO, CDC4, FBW6, FBW7, hAgo, FBX30, FBXW6, SEL10, hCdc4, FBXO30, SEL-10 | | -FBXW7 and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| 46 |
CD22 | 19q13.12 | SIGLEC2, SIGLEC-2 | | -CD22 and Acute Lymphocytic Leukaemia
| 43 |
ABL1 | 9q34.12 | ABL, JTK7, p150, c-ABL, v-abl, c-ABL1, bcr/abl | Translocation
| -BCR-ABL Translocation in Acute Lymphoblastic Leukaemia -NUP214-ABL1 rearrangements in T-Cell Acute Lymphoblastic Leukemia
| 39 |
NUP214 | 9q34.13 | CAN, CAIN | Translocation
| -NUP214-ABL1 rearrangements in T-Cell Acute Lymphoblastic Leukemia
| 39 |
RUNX1 | 21q22.12 | AML1, CBFA2, EVI-1, AMLCR1, PEBP2aB, CBF2alpha, AML1-EVI-1, PEBP2alpha | Translocation
| -t(12;21) in Adult Lyphocytic Leukaemia
| 38 |
TLX1 | 10q24.31 | TCL3, HOX11 | | -TLX1 and Acute Lymphocytic Leukaemia
| 38 |
TRG | 7p14.1 | TCRG, TRG@ | | -TRG and Acute Lymphoblastic Leukemia
| 37 |
TCF3 | 19p13.3 | E2A, E47, AGM8, ITF1, VDIR, TCF-3, bHLHb21 | Translocation
| -t(17;19)(q22;p13) TCF3-HLF fusion in Acute Lymphoblastic Leukemia
| 35 |
SLC19A1 | 21q22.3 | RFC, CHMD, FOLT, IFC1, REFC, RFC1, hRFC, IFC-1, RFT-1 | | -SLC19A1 and Acute Lymphocytic Leukaemia
| 33 |
ARHGEF1 | 19q13.2 | LSC, GEF1, LBCL2, SUB1.5, P115-RHOGEF | | -ARHGEF1 and Acute Lymphocytic Leukaemia
| 33 |
TLX3 | 5q35.1 | RNX, HOX11L2 | | -TLX3 and Acute Lymphocytic Leukaemia
| 30 |
IGK | 2p12 | IGK@ | | -IGK and Acute Lymphocytic Leukaemia
| 29 |
CD79A | 19q13.2 | IGA, MB-1 | | -CD79A and Acute Lymphocytic Leukaemia
| 28 |
STAM | 10p12.33 | STAM1, STAM-1 | | -STAM and Acute Lymphocytic Leukaemia
| 28 |
TPMT | 6p22.3 | TPMTD | | -TPMT and Acute Lymphocytic Leukaemia
| 26 |
GALE | 1p36.11 | SDR1E1 | | -GALE and Acute Lymphocytic Leukaemia
| 26 |
CEBPE | 14q11.2 | CRP1, C/EBP-epsilon | | -CEBPE and Acute Lymphocytic Leukaemia
| 25 |
EBF1 | 5q33.3 | EBF, COE1, OLF1, O/E-1 | | -EBF1 and Acute Lymphocytic Leukaemia
| 25 |
CYP1A1 | 15q24.1 | AHH, AHRR, CP11, CYP1, CYPIA1, P1-450, P450-C, P450DX | | -CYP1A1 and Acute Lymphocytic Leukaemia
| 25 |
ABL2 | 1q25.2 | ARG, ABLL | Translocation
| -t(1;12)(q25;p13) in Leukaemia (AML & ALL)
| 25 |
TAL1 | 1p33 | SCL, TCL5, tal-1, bHLHa17 | | -TAL1 and Acute Lymphocytic Leukaemia
| 24 |
TRB | 7q34 | TCRB, TRB@ | Translocation
| -t(7;9)(q34;q34) in T-Cell Acute Lymphoblastic Leukaemia -t(7;19)(q35;p13) in T-cell Acute Lymphoblastic Leukemia -TRB and Acute Lymphocytic Leukaemia
| 17 |
DHFR | 5q14.1 | DYR, DHFRP1 | | -DHFR and Acute Lymphocytic Leukaemia
| 23 |
ELL | 19p13.11 | MEN, ELL1, PPP1R68, C19orf17 | Translocation
| -ELL and Acute Lymphocytic Leukaemia -t(11;19)(q23;p13.1) MLL-ELL translocation in acute leukaemia
| 18 |
HLA-DRB1 | 6p21.32 | SS1, DRB1, HLA-DRB, HLA-DR1B | | -HLA-DRB1 and Acute Lymphocytic Leukaemia
| 22 |
P2RY8 | Xp22.33; Yp11.3 | P2Y8 | | -P2RY8 and Acute Lymphocytic Leukaemia
| 20 |
IL7R | 5p13.2 | ILRA, CD127, IL7RA, CDW127, IL-7R-alpha | | -IL7R and Acute Lymphocytic Leukaemia
| 20 |
CD14 | 5q31.3 | | | -CD14 and Acute Lymphocytic Leukaemia
| 19 |
MCL1 | 1q21.2 | TM, EAT, MCL1L, MCL1S, Mcl-1, BCL2L3, MCL1-ES, bcl2-L-3, mcl1/EAT | | -MCL1 and Acute Lymphocytic Leukaemia
| 19 |
ABCG2 | 4q22.1 | MRX, MXR, ABCP, BCRP, BMDP, MXR1, ABC15, BCRP1, CD338, GOUT1, MXR-1, CDw338, UAQTL1, EST157481 | | -ABCG2 and Acute Lymphocytic Leukaemia
| 19 |
JAK3 | 19p13.11 | JAKL, LJAK, JAK-3, L-JAK, JAK3_HUMAN | | -JAK3 and Acute Lymphocytic Leukaemia
| 19 |
TYMS | 18p11.32 | TS, TMS, HST422 | | -TYMS and Acute Lymphocytic Leukaemia
| 18 |
JAK2 | 9p24.1 | JTK10, THCYT3 | | -JAK2 mutations in Down syndrome-associated ALL
| 17 |
FAS | 10q23.31 | APT1, CD95, FAS1, APO-1, FASTM, ALPS1A, TNFRSF6 | | -FAS and Acute Lymphoblastic Leukaemia
| 16 |
RFC1 | 4p14 | A1, RFC, PO-GA, RECC1, MHCBFB, RFC140 | | -RFC1 and Acute Lymphocytic Leukaemia
| 16 |
FHIT | 3p14.2 | FRA3B, AP3Aase | | -FHIT and Acute Lymphocytic Leukaemia
| 16 |
LMO1 | 11p15.4 | TTG1, RBTN1, RHOM1 | | -LMO1 and T-Cell Leukemia-Lymphoma
| 16 |
LEF1 | 4q25 | LEF-1, TCF10, TCF7L3, TCF1ALPHA | | -LEF1 and Acute Lymphocytic Leukaemia
| 14 |
CD1A | 1q23.1 | R4, T6, CD1, FCB6, HTA1 | | -CD1A and Acute Lymphocytic Leukaemia
| 13 |
NR3C1 | 5q31.3 | GR, GCR, GRL, GCCR, GCRST | | -NR3C1 and Acute Lymphocytic Leukaemia
| 13 |
BTG1 | 12q21.33 | APRO2 | | -BTG1 and Acute Lymphocytic Leukaemia
| 11 |
SHMT1 | 17p11.2 | SHMT, CSHMT | | -SHMT1 and Acute Lymphocytic Leukaemia
| 11 |
SLCO1B1 | 12p12.1 | LST1, HBLRR, LST-1, OATP2, OATPC, OATP-C, OATP1B1, SLC21A6 | | -SLCO1B1 and Acute Lymphocytic Leukaemia
| 11 |
FPGS | 9q34.11 | | | -FPGS and Acute Lymphocytic Leukaemia
| 10 |
CD79B | 17q23.3 | B29, IGB, AGM6 | | -CD79B and Acute Lymphocytic Leukaemia
| 10 |
RAG2 | 11p12 | RAG-2 | | -RAG2 and Acute Lymphocytic Leukaemia
| 10 |
RAG1 | 11p12 | RAG-1, RNF74 | | -RAG1 and Acute Lymphocytic Leukaemia
| 9 |
MTHFD1 | 14q23.3 | MTHFC, MTHFD | | -MTHFD1 and Acute Lymphocytic Leukaemia
| 9 |
IL15 | 4q31.21 | IL-15 | | -IL15 and Acute Lymphocytic Leukaemia
| 9 |
MLLT3 | 9p21.3 | AF9, YEATS3 | | -MLLT3 and Acute Lymphocytic Leukaemia
| 9 |
ZNF384 | 12p13.31 | NP, CIZ, NMP4, CAGH1, ERDA2, TNRC1, CAGH1A | | -ZNF384 and Acute Lymphocytic Leukaemia
| 9 |
HLA-DPB1 | 6p21.32 | DPB1, HLA-DP, HLA-DPB, HLA-DP1B | | -HLA-DPB1 and Acute Lymphocytic Leukaemia
| 9 |
TCF7L1 | 2p11.2 | TCF3, TCF-3 | | -TCF7L1 and Acute Lymphocytic Leukaemia
| 8 |
MTAP | 9p21.3 | BDMF, MSAP, DMSFH, LGMBF, DMSMFH, c86fus, HEL-249 | | -MTAP and Acute Lymphocytic Leukaemia
| 8 |
STIL | 1p33 | SIL, MCPH7 | | -STIL and Adult T-Cell Leukemia-Lymphoma
| 8 |
MLLT1 | 19p13.3 | ENL, LTG19, YEATS1 | | -MLLT1 and Acute Lymphocytic Leukaemia
| 8 |
CASP8AP2 | 6q15 | CED-4, FLASH, RIP25 | | -CASP8AP2 and Acute Lymphocytic Leukaemia
| 8 |
ABCC4 | 13q32.1 | MRP4, MOATB, MOAT-B | | -ABCC4 and Acute Lymphocytic Leukaemia
| 8 |
HFE | 6p22.2 | HH, HFE1, HLA-H, MVCD7, TFQTL2 | | -HFE and Acute Lymphocytic Leukaemia
| 7 |
MEF2C | 5q14.3 | DEL5q14.3, C5DELq14.3 | | -MEF2C and Acute Lymphocytic Leukaemia
| 7 |
CEACAM6 | 19q13.2 | NCA, CEAL, CD66c | | -CEACAM6 and Acute Lymphocytic Leukaemia
| 7 |
HOXA7 | 7p15.2 | ANTP, HOX1, HOX1A, HOX1.1 | | -HOXA7 and Acute Lymphocytic Leukaemia
| 7 |
CD58 | 1p13.1 | ag3, LFA3, LFA-3 | | -CD58 and Acute Lymphocytic Leukaemia
| 6 |
BIRC7 | 20q13.33 | KIAP, LIVIN, MLIAP, RNF50, ML-IAP | | -BIRC7 and Acute Lymphocytic Leukaemia
| 6 |
PMS2 | 7p22.1 | MLH4, PMSL2, HNPCC4, PMS2CL | | -PMS2 and Acute Lymphocytic Leukaemia
| 6 |
IL7 | 8q21.13 | IL-7 | | -IL7 and Acute Lymphocytic Leukaemia
| 6 |
SLC29A1 | 6p21.1 | ENT1 | | -SLC29A1 and Acute Lymphocytic Leukaemia
| 6 |
OLAH | 10p13 | SAST, AURA1, THEDC1 | | -OLAH and Acute Lymphocytic Leukaemia
| 6 |
PRAME | 22q11.22 | MAPE, OIP4, CT130, OIP-4 | | -PRAME and Acute Lymphocytic Leukaemia
| 6 |
IDH1 | 2q33.3 | IDH, IDP, IDCD, IDPC, PICD, HEL-216, HEL-S-26 | | -IDH1 and Acute Lymphocytic Leukaemia
| 6 |
TAF15 | 17q12 | Npl3, RBP56, TAF2N, TAFII68 | | -TAF15 and Acute Lymphocytic Leukaemia
| 5 |
TYK2 | 19p13.2 | JTK1, IMD35 | | -TYK2 and Acute Lymphocytic Leukaemia
| 5 |
SLC19A2 | 1q24.2 | TC1, THT1, TRMA, THMD1, THTR1 | | -SLC19A2 and Acute Lymphocytic Leukaemia
| 5 |
PBX3 | 9q33.3 | | | -PBX3 and Acute Lymphocytic Leukaemia
| 5 |
CCNC | 6q21 | CycC | | -CCNC and Acute Lymphocytic Leukaemia
| 5 |
AFF3 | 2q11.2-q12 | LAF4, MLLT2-like | | -AFF3 and Acute Lymphocytic Leukaemia
| 5 |
BCL2L11 | 2q13 | BAM, BIM, BOD | | -BCL2L11 and Acute Lymphocytic Leukaemia
| 5 |
GAST | 17q21.2 | GAS | | -GAST and Acute Lymphocytic Leukaemia
| 5 |
ROR1 | 1p31.3 | NTRKR1, dJ537F10.1 | | -ROR1 and Acute Lymphocytic Leukaemia
| 5 |
CTLA4 | 2q33 | CD, GSE, GRD4, ALPS5, CD152, CTLA-4, IDDM12, CELIAC3 | | -CTLA4 and Acute Lymphocytic Leukaemia
| 5 |
ABCC2 | 10q24.2 | DJS, MRP2, cMRP, ABC30, CMOAT | | -ABCC2 and Acute Lymphocytic Leukaemia
| 5 |
NOD2 | 16q12.1 | CD, ACUG, BLAU, IBD1, YAOS, BLAUS, NLRC2, NOD2B, CARD15, CLR16.3, PSORAS1 | | -NOD2 and Acute Lymphocytic Leukaemia
| 4 |
TFPT | 19q13.42 | FB1, amida, INO80F | | -TFPT and Acute Lymphocytic Leukaemia
| 4 |
PTPRG | 3p21-p14 | PTPG, HPTPG, RPTPG, R-PTP-GAMMA | | -PTPRG and Acute Lymphocytic Leukaemia
| 4 |
ZNF521 | 18q11.2 | EHZF, Evi3 | | -ZNF521 and Acute Lymphocytic Leukaemia
| 4 |
CD83 | 6p23 | BL11, HB15 | | -CD83 and Acute Lymphocytic Leukaemia
| 4 |
CD3D | 11q23.3 | T3D, IMD19, CD3-DELTA | | -CD3D and Acute Lymphocytic Leukaemia
| 4 |
RANBP17 | 5q35.1 | | | -RANBP17 and Acute Lymphocytic Leukaemia
| 4 |
CD69 | 12p13.31 | AIM, EA1, MLR-3, CLEC2C, GP32/28, BL-AC/P26 | | -CD69 and Acute Lymphocytic Leukaemia
| 4 |
MIR126 | 9q34.3 | MIRN126, mir-126, miRNA126 | | -MicroRNA mir-126 and Acute Lymphocytic Leukaemia
| 4 |
TET1 | 10q21.3 | LCX, CXXC6, bA119F7.1 | Translocation
| -t(10;11) MLL-TET1 rearrangement in acute leukemias
| 4 |
SFPQ | 1p34.3 | PSF, POMP100, PPP1R140 | | -SFPQ and Acute Lymphocytic Leukaemia
| 3 |
FMR1 | Xq27.3 | POF, FMRP, POF1, FRAXA | | -FMR1 and Acute Lymphocytic Leukaemia
| 3 |
PRF1 | 10q22.1 | P1, PFP, FLH2, PFN1, HPLH2 | | -PRF1 and Acute Lymphocytic Leukaemia
| 3 |
GSTO1 | 10q25.1 | P28, SPG-R, GSTO 1-1, GSTTLp28, HEL-S-21 | | -GSTO1 and Acute Lymphocytic Leukaemia
| 3 |
NNAT | 20q11.23 | Peg5 | | -NNAT and Acute Lymphocytic Leukaemia
| 3 |
IL2RB | 22q12.3 | CD122, IMD63, IL15RB, P70-75 | | -IL2RB and Acute Lymphocytic Leukaemia
| 3 |
CHFR | 12q24.33 | RNF116, RNF196 | | -CHFR and Acute Lymphocytic Leukaemia
| 3 |
HCK | 20q11.21 | JTK9, p59Hck, p61Hck | | -HCK and Acute Lymphocytic Leukaemia
| 3 |
PTER | 10p13 | HPHRP, RPR-1 | | -PTER and Acute Lymphocytic Leukaemia
| 3 |
CD55 | 1q32.2 | CR, TC, DAF, CROM, CHAPLE | | -CD55 and Acute Lymphocytic Leukaemia
| 3 |
HOXC6 | 12q13.13 | CP25, HOX3, HOX3C, HHO.C8 | | -HOXC6 and Acute Lymphocytic Leukaemia
| 3 |
CD70 | 19p13.3 | CD27L, CD27-L, CD27LG, TNFSF7, TNLG8A | | -CD70 and Acute Lymphocytic Leukaemia
| 3 |
MLLT6 | 17q12 | AF17 | | -MLLT6 and Acute Lymphocytic Leukaemia
| 2 |
LRRC3B | 3p24.1 | LRP15 | | -LRRC3B and Acute Lymphocytic Leukaemia
| 2 |
CDK2AP1 | 12q24.31 | DOC1, ST19, DORC1, doc-1, p12DOC-1 | | -CDK2AP1 and Acute Lymphocytic Leukaemia
| 2 |
B2M | 15q21.1 | IMD43 | | -B2M and Acute Lymphocytic Leukaemia
| 2 |
TTL | 2q13 | | | -TTL and Acute Lymphocytic Leukaemia
| 2 |
TFRC | 3q29 | T9, TR, TFR, p90, CD71, TFR1, TRFR, IMD46 | | -TFRC and Acute Lymphocytic Leukaemia
| 2 |
MNX1 | 7q36.3 | HB9, HLXB9, SCRA1, HOXHB9 | | -MNX1 and Acute Lymphocytic Leukaemia
| 2 |
BLNK | 10q24.1 | bca, AGM4, BASH, LY57, SLP65, BLNK-S, SLP-65 | | -BLNK and Acute Lymphocytic Leukaemia
| 2 |
CTNND1 | 11q12.1 | CAS, p120, CTNND, P120CAS, P120CTN, p120(CAS), p120(CTN) | | -CTNND1 and Acute Lymphocytic Leukaemia
| 2 |
RASSF10 | 11p15.3 | | | -RASSF10 and Acute Lymphocytic Leukaemia
| 1 |
PECAM1 | 17q23.3 | CD31, PECA1, GPIIA', PECAM-1, endoCAM, CD31/EndoCAM | | -PECAM1 and Acute Lymphocytic Leukaemia
| 1 |
ARHGEF12 | 11q23.3 | LARG, PRO2792 | | -ARHGEF12 and Acute Lymphocytic Leukaemia
| 1 |
NR3C2 | 4q31.23 | MR, MCR, MLR, NR3C2VIT | | -NR3C2 and Acute Lymphocytic Leukaemia
| 1 |
FCRL4 | 1q23.1 | FCRH4, IGFP2, IRTA1, CD307d | | -FCRL4 and Acute Lymphocytic Leukaemia
| 1 |
RASSF6 | 4q13.3 | | | -RASSF6 and Acute Lymphocytic Leukaemia
| 1 |
ITGB2 | 21q22.3 | LAD, CD18, MF17, MFI7, LCAMB, LFA-1, MAC-1 | | -ITGB2 and Acute Lymphocytic Leukaemia
| 1 |
ARHGAP26 | 5q31.3 | GRAF, GRAF1, OPHN1L, OPHN1L1 | | -ARHGAP26 and Acute Lymphocytic Leukaemia
| 1 |
PNN | 14q21.1 | DRS, DRSP, SDK3, memA | | -PNN and Acute Lymphocytic Leukaemia
| 1 |
SNRPE | 1q32.1 | SME, Sm-E, HYPT11, snRNP-E | | -SNRPE and Acute Lymphocytic Leukaemia
| 1 |
ADIPOQ | 3q27 | ACDC, ADPN, APM1, APM-1, GBP28, ACRP30, ADIPQTL1 | | -ADIPOQ and Acute Lymphocytic Leukaemia
| 1 |
ACKR3 | 2q37.3 | RDC1, CXCR7, RDC-1, CMKOR1, CXC-R7, CXCR-7, GPR159 | | -ACKR3 and Acute Lymphocytic Leukaemia
| 1 |
DOK2 | 8p21.3 | p56DOK, p56dok-2 | | -DOK2 and Acute Lymphocytic Leukaemia
| 1 |
CEACAM3 | 19q13.2 | CEA, CGM1, W264, W282, CD66D | | -CEACAM3 and Acute Lymphocytic Leukaemia
| 1 |
TPD52L1 | 6q22.31 | D53 | | -TPD52L1 and Acute Lymphocytic Leukaemia
| 1 |
FCGR2B | 1q23.3 | CD32, FCG2, CD32B, FCGR2, IGFR2, FCGR2C, FcRII-c | | -FCGR2B and Acute Lymphocytic Leukaemia
| 1 |
PRTN3 | 19p13.3 | MBN, MBT, NP4, P29, PR3, ACPA, AGP7, NP-4, PR-3, CANCA, C-ANCA | | -PRTN3 and Acute Lymphocytic Leukaemia
| 1 |
SOCS1 | 16p13.13 | JAB, CIS1, SSI1, TIP3, CISH1, SSI-1, SOCS-1 | | -SOCS1 and Acute Lymphocytic Leukaemia
| 1 |
DPH1 | 17p13.3 | DPH2L, OVCA1, DEDSSH, DPH2L1 | | -DPH1 and Acute Lymphocytic Leukaemia
| 1 |
IFNA17 | 9p21.3 | IFNA, INFA, LEIF2C1, IFN-alphaI | | -IFNA17 and Acute Lymphocytic Leukaemia
| |
SERPINC1 | 1q25.1 | AT3, AT3D, ATIII, THPH7, ATIII-R2, ATIII-T1, ATIII-T2 | | -SERPINC1 and Acute Lymphocytic Leukaemia
| |
IFNA2 | 9p21.3 | IFNA, INFA2, IFNA2B, IFN-alphaA | | -IFNA2 and Acute Lymphocytic Leukaemia
| |
IFNA7 | 9p21.3 | IFNA-J, IFN-alphaJ | | -IFNA7 and Acute Lymphocytic Leukaemia
| |
TNFRSF8 | 1p36.22 | CD30, Ki-1, D1S166E | | -TNFRSF8 and Acute Lymphocytic Leukaemia
| |
LYL1 | 19p13.13 | bHLHa18 | Translocation
| -t(7;19)(q35;p13) in T-cell Acute Lymphoblastic Leukemia
| |
BCL2 | 18q21.33 | Bcl-2, PPP1R50 | Translocation
| -t(14;18)(q32;q21) in Acute Lymphoblastic Leukaemia
| |
AFF1 | 4q21.3-q22.1 | AF4, PBM1, MLLT2 | Translocation
| -t(4;11)(q21;q23) MLL-AFF1 in adult acute lymphoblastic leukemia
| |